Trans Sodium Crocetinate (TSC) Study of Intra-tumoral Oxygen Concentration, Safety, and Pharmacokinetics in Patients With High Grade Glioma

This study has been terminated.

( Sponsor business decision, not based on safety or efficacy data. )

Study NCT00826930 Information provided by Diffusion Pharmaceuticals LLC

First Received: January 21, 2009 Last Updated: September 11, 2009 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	September 2009
Primary Completion Date:	September 2009 (Final data collection date for primary outcome measure)